Search results
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with...
Casper Star-Tribune· 6 days agoArbele, a clinical-stage biotechnology company focused on the development of novel immunotherapies targeted for advanced gastrointestinal cancers, today announced the positive ...
abrdn plc Boosts Holdings in Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 5 days agoThe firm owned 106,106 shares of the medical research company’s stock after purchasing an additional 34,494 shares during the period. Artisan Partners Limited Partnership raised its stake in ...
Less alcohol, or none at all, is one path to better health, new study finds
KSL Salt Lake City· 3 days agoIt's time to rethink drinking, new studies show. Moderate drinking was once thought to have benefits...